Public Health · 2 h ago
EMA launches voluntary data submission pilot for alternatives to animal testing
The European Medicines Agency has launched a voluntary data submission pilot for New Approach Methodologies, intended to advance alternatives to animal testing. Developers can submit data generated using these methods and receive tailored feedback.
- EMA launched a voluntary pilot for sharing NAMs data.
- Developers can receive tailored feedback on submitted data.
- The supplied notice provides no method validation results.
The European Medicines Agency (EMA) has announced a voluntary data submission pilot to facilitate sharing of data generated using New Approach Methodologies (NAMs), described as innovative alternatives to animal testing. The notice, dated 1 September 2026 and listed under human and veterinary medicines, states that developers can submit NAMs data and receive tailored feedback. The initiative concerns methodological development rather than findings from a clinical study. The supplied text does not describe eligibility criteria, submission procedures, evaluation standards or how feedback might inform subsequent regulatory decisions. It also provides no results demonstrating the performance of specific methods or their suitability to replace animal testing in particular settings.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
European Medicines Agency: Voluntary data submission pilot to advance innovative alternatives to animal testing ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.